Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.400
-0.140 (-5.51%)
At close: Dec 5, 2025, 4:00 PM EST
2.440
+0.040 (1.67%)
After-hours: Dec 5, 2025, 7:20 PM EST
CNTB Stock Forecast
Stock Price Forecast
The 4 analysts that cover CNTB stock have a consensus rating of "Strong Buy" and an average price target of $8.50, which forecasts a 254.17% increase in the stock price over the next year. The lowest target is $7.00 and the highest is $10.
Price Target: $8.50 (+254.17%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CNTB stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +275.00% | Dec 1, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +316.67% | Nov 13, 2025 |
| BTIG | BTIG | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +316.67% | Oct 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +191.67% | Aug 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +191.67% | Jun 12, 2025 |
Financial Forecast
Revenue This Year
193.60K
from 26.03M
Decreased by -99.26%
Revenue Next Year
74.32M
from 193.60K
Increased by 38,289.22%
EPS This Year
-4.26
from -0.28
EPS Next Year
-3.60
from -4.26
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 746,760 | 152.3M | ||||
| Avg | 193,596 | 74.3M | ||||
| Low | n/a | 696,976 |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -97.1% | 78,548.3% | ||||
| Avg | -99.3% | 38,289.2% | ||||
| Low | - | 260.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.05 | -0.89 | ||||
| Avg | -4.26 | -3.60 | ||||
| Low | -7.25 | -7.18 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.